CORT Corcept Therapeutics Inc

2,776

$27.04

$0.58

(2.19%)

Today

Watchers	2,776
52-Wk Low	$17.86
52-Wk High	$34.28

Market Cap	$2.86B
Volume (M)	367,993.00
52-Wk High	$34.28
52-Wk Low	$17.86

Fundamentals

Corcept Therapeutics (CORT, $26.25) price may drop as it broke higher Bollinger Band on Dec 04, 2023Tickeron - Stocks • 1 day ago

This price move could be a signal that CORT may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Share to Feed

Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Great West Life Assurance Co. CanZolmax • 3 days ago

Great West Life Assurance Co. Can lessened its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT Free Report) by 10.2% during the 2nd quarter, according to its most recent 13F filing...

Corcept Therapeutics (CORT) Gets a Buy from Piper SandlerTipRanks Financial Blog • 6 days ago

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Corcept Therapeutics (CORT Research Report), with a pric...

Renaissance Technologies LLC Cuts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Ticker Report • 7 days ago

Renaissance Technologies LLC lowered its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT Free Report) by 1.3% during the 2nd quarter, according to the company in its most recent...

Truist Financial Corp Cuts Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Zolmax • 22 days ago

Truist Financial Corp trimmed its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT Free Report) by 68.7% during the 2nd quarter, according to its most recent Form 13F filing with...

Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives Consensus Recommendation of "Moderate Buy" from AnalystsZolmax • 22 days ago

Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT Get Free Report) have been assigned a consensus recommendation of Moderate Buy from the seven research firms that are...

Corcept Therapeutics management to meet with Piper SandlerThe Fly • 24 days ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Corcept Therapeutics (CORT, $24.91) RSI Indicator left the oversold zone on November 09, 2023Tickeron - Stocks • 27 days ago

This is a signal that CORT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Corcept Therapeutics management to meet with Piper SandlerThe Fly • 29 days ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Corcept Therapeutics upgraded to Buy from Hold at TruistThe Fly • about 1 month ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...